Abiopharma

New Form 10-Q - Grace Therapeutics, Inc. Filed: 2025-08-12 AccNo: 0001140361-25-030398 Size: 5 MB

New Form 10-Q - TScan Therapeutics, Inc. Filed: 2025-08-12 AccNo: 0000950170-25-106919 Size: 7 MB

New Form 8-K - CalciMedica, Inc. Filed: 2025-08-12 AccNo: 0000950170-25-106918 Size: 492 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form 8-K - VERU INC. Filed: 2025-08-12 AccNo: 0001437749-25-026037 Size: 222 KB Item 3.03: Material Modifications to Rights of Security Holders Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

ADC - ADC Therapeutics Reports Second Quarter 2025 Financial Results and Provides Operational Update

ADC Therapeutics Reports Second Quarter 2025 Financial Results and Provides Operational Update

Anavex Life Sciences Reports Fiscal 2025 Third Quarter Financial Results and Provides Business Update

New Form S-8 - Milestone Pharmaceuticals Inc. Filed: 2025-08-12 AccNo: 0001104659-25-076479 Size: 216 KB

Gain Therapeutics Reports Financial Results for Second Quarter 2025 and Provides Corporate Update

New Form 8-K - Milestone Pharmaceuticals Inc. Filed: 2025-08-12 AccNo: 0001104659-25-076468 Size: 288 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form 10-Q - Climb Bio, Inc. Filed: 2025-08-12 AccNo: 0000950170-25-106916 Size: 10 MB

New Form 10-Q - Passage BIO, Inc. Filed: 2025-08-12 AccNo: 0001558370-25-011146 Size: 7 MB

New Form 8-K - TScan Therapeutics, Inc. Filed: 2025-08-12 AccNo: 0000950170-25-106915 Size: 424 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form 10-Q - Centessa Pharmaceuticals plc Filed: 2025-08-12 AccNo: 0001847903-25-000135 Size: 7 MB

New Form 10-Q - Korro Bio, Inc. Filed: 2025-08-12 AccNo: 0000950170-25-106912 Size: 9 MB